DE2619638A1 - Pyrrolidone und verfahren zu ihrer herstellung - Google Patents

Pyrrolidone und verfahren zu ihrer herstellung

Info

Publication number
DE2619638A1
DE2619638A1 DE19762619638 DE2619638A DE2619638A1 DE 2619638 A1 DE2619638 A1 DE 2619638A1 DE 19762619638 DE19762619638 DE 19762619638 DE 2619638 A DE2619638 A DE 2619638A DE 2619638 A1 DE2619638 A1 DE 2619638A1
Authority
DE
Germany
Prior art keywords
formula
compound
group
pyrrolidone
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19762619638
Other languages
German (de)
English (en)
Inventor
Gerhard Beck
Rudolf Dipl Chem Dr Kunstmann
Ulrich Dipl Chem Dr Lerch
Bernward Dr Schoelkens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to DE19762619638 priority Critical patent/DE2619638A1/de
Priority to ES458264A priority patent/ES458264A1/es
Priority to NL7704739A priority patent/NL7704739A/xx
Priority to IT23096/77A priority patent/IT1086223B/it
Priority to GB18427/77A priority patent/GB1583163A/en
Priority to DK194377A priority patent/DK194377A/da
Priority to FR7713518A priority patent/FR2372806A1/fr
Priority to JP5194577A priority patent/JPS52133975A/ja
Priority to BE177278A priority patent/BE854268A/xx
Publication of DE2619638A1 publication Critical patent/DE2619638A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19762619638 1976-05-04 1976-05-04 Pyrrolidone und verfahren zu ihrer herstellung Pending DE2619638A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE19762619638 DE2619638A1 (de) 1976-05-04 1976-05-04 Pyrrolidone und verfahren zu ihrer herstellung
ES458264A ES458264A1 (es) 1976-05-04 1977-04-28 Procedimiento para la preparacion de nuevos compuestos ana- logos a prostaglandinas.
NL7704739A NL7704739A (nl) 1976-05-04 1977-04-29 Pyrrolidonen en de bereiding daarvan.
IT23096/77A IT1086223B (it) 1976-05-04 1977-05-02 Pirrolidoni e processo per la loro preparazione
GB18427/77A GB1583163A (en) 1976-05-04 1977-05-03 Pyrrolidones and process for their manufacutre
DK194377A DK194377A (da) 1976-05-04 1977-05-03 Pyrrolidoner samt deres fremstilling og anvendelse
FR7713518A FR2372806A1 (fr) 1976-05-04 1977-05-04 Pyrrolidones, leur procede de preparation et leur application therapeutique
JP5194577A JPS52133975A (en) 1976-05-04 1977-05-04 Pyrrolidones and their preparation
BE177278A BE854268A (fr) 1976-05-04 1977-05-04 Pyrrolidones, leur procede de preparation et leur application therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762619638 DE2619638A1 (de) 1976-05-04 1976-05-04 Pyrrolidone und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DE2619638A1 true DE2619638A1 (de) 1977-11-17

Family

ID=5977020

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762619638 Pending DE2619638A1 (de) 1976-05-04 1976-05-04 Pyrrolidone und verfahren zu ihrer herstellung

Country Status (9)

Country Link
JP (1) JPS52133975A (ja)
BE (1) BE854268A (ja)
DE (1) DE2619638A1 (ja)
DK (1) DK194377A (ja)
ES (1) ES458264A1 (ja)
FR (1) FR2372806A1 (ja)
GB (1) GB1583163A (ja)
IT (1) IT1086223B (ja)
NL (1) NL7704739A (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320136A (en) 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4321201A (en) 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
EP1110949A1 (en) * 1999-12-22 2001-06-27 Pfizer Products Inc. EP4 receptor selective agonists in the treatment of osteoporosis
US6747054B2 (en) 2000-11-27 2004-06-08 Pfizer Inc. EP4 receptor selective agonists in the treatment of osteoporosis
WO2014144610A1 (en) * 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989010359A1 (en) * 1988-04-22 1989-11-02 2 Moskovsky Gosudarstvenny Meditsinsky Institut Im Carbalkoxymethyl ethers of lactam-1-acetic acid and method of obtaining them
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
DK1408961T3 (da) 2001-07-16 2007-11-05 Hoffmann La Roche 2 pyrrolidon-derivater som prostanoide agonister
KR20040015364A (ko) * 2001-07-16 2004-02-18 에프. 호프만-라 로슈 아게 Ｅｐ4 수용체 작용물질로서의 프로스타글란딘 유사체
IL159996A0 (en) * 2001-07-23 2004-06-20 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
WO2003074483A1 (fr) 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. Composes derives de 8 azaprostaglandine et medicaments contenant ceux-ci comme principe actif
WO2003103604A2 (en) * 2002-06-01 2003-12-18 Applied Research Systems Ars Holding N.V Gamma lactams as prostaglandin agonists and use thereof
CN1735597A (zh) 2003-01-10 2006-02-15 霍夫曼-拉罗奇有限公司 作为前列腺素激动剂的2－哌啶酮衍生物
WO2004065365A1 (ja) * 2003-01-21 2004-08-05 Ono Pharmaceutical Co., Ltd. ８−アザプロスタグランジン誘導体およびその医薬用途
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
JP4893999B2 (ja) 2004-10-22 2012-03-07 小野薬品工業株式会社 吸入用医薬組成物
WO2014015247A1 (en) 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
EP3235817B1 (en) 2013-03-15 2018-12-12 Cayman Chemical Company, Incorporated Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
AU2014229065B2 (en) 2013-03-15 2017-03-09 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320136A (en) 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4321201A (en) 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
EP1110949A1 (en) * 1999-12-22 2001-06-27 Pfizer Products Inc. EP4 receptor selective agonists in the treatment of osteoporosis
WO2001046140A1 (en) * 1999-12-22 2001-06-28 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
US6747054B2 (en) 2000-11-27 2004-06-08 Pfizer Inc. EP4 receptor selective agonists in the treatment of osteoporosis
US7192979B2 (en) 2000-11-27 2007-03-20 Pfizer Inc. EP4 receptor selective agonist in the treatment of osteoporosis
WO2014144610A1 (en) * 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions

Also Published As

Publication number Publication date
FR2372806B1 (ja) 1980-02-29
GB1583163A (en) 1981-01-21
IT1086223B (it) 1985-05-28
FR2372806A1 (fr) 1978-06-30
ES458264A1 (es) 1978-07-16
DK194377A (da) 1977-11-05
JPS52133975A (en) 1977-11-09
NL7704739A (nl) 1977-11-08
BE854268A (fr) 1977-11-04

Similar Documents

Publication Publication Date Title
DE2619638A1 (de) Pyrrolidone und verfahren zu ihrer herstellung
DD207713A1 (de) Substituierte imidazolabkoemmlinge, ihre herstellung und verwendung
CH642629A5 (de) Am stickstoffatom substituierte moranolin-derivate.
DE2528664A1 (de) Pyrrolidone und verfahren zu ihrer herstellung
DD144408A5 (de) Verfahren zur herstellung von n-alkylimidazolderivaten
DE2229035A1 (de) Cyclopentanderivate
DE69101141T2 (de) Neue Guanidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
EP0535420A1 (de) Acylale von Imidazol-5-carbonsäurederivaten, als Angiotensin II Inhibitoren
EP0033156B1 (de) 1-Phenyl-2-cyclohexen-1-alkylamin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2422924A1 (de) Thiaprostaglandine
DE2739277A1 (de) 11-deoxy-11-oxaprostaglandinverbindungen
EP0298921B1 (de) 1,2-Benzisoxazole und 1,2-Benzisothiazole
DE2346706A1 (de) Neue, nicht natuerlich vorkommende analoga von prostansaeuren und verfahren zu ihrer herstellung
DE2611788C2 (de) Fluorprostaglandine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DE2242454A1 (de) 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2556326A1 (de) Neue pyrrolidone und verfahren zu ihrer herstellung
DE2917456C2 (ja)
DE2331081A1 (de) Neue cyclopentanderivate und verfahren zu ihrer herstellung
EP0013955A1 (de) Neue Analoga von Prostacyclin, deren Zwischenprodukte, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2757766A1 (de) 1-substituierte-3-aminoaethoxypyrrolidine, ihre herstellung und verwendung als blutdrucksenkendes mittel
DE2644972A1 (de) Thiaprostaglandine
DE2513371C2 (de) 9,11,15-Trihydroxy-13-thia-5-prostensäure-Derivate und diese enthaltende pharmazeutische Zubereitungen
DE2502919A1 (de) Cyclopentan-derivate
DE1795597A1 (de) Verfahren zur Herstellung von Dibenzoxepinen,Dibenzthiepinen und Thioxanthenen
CH617676A5 (ja)

Legal Events

Date Code Title Description
OHN Withdrawal